Serinus Biosciences Analysis: $500K Raised

430 East 29th Street, New York City, New York, United States

The main competitors of Serinus Biosciences in the market of cancer drug resistance and AI-driven drug discovery include:

1. Owkin: Focuses on using AI to improve drug development and patient outcomes by analyzing patient data and biological information. Their advantage lies in their strong emphasis on machine learning to predict patient responses to treatments.

2. BigHat Biosciences: Specializes in using AI to design and optimize therapeutic antibodies. Their notable difference is their focus on antibody engineering, which complements Serinus's focus on druggable vulnerabilities in resistant tumors.

3. AbSci: Utilizes a unique platform for protein expression and drug discovery, particularly in biologics. Their advantage is in their ability to rapidly produce complex proteins, which can be crucial in developing new cancer therapies.

4. Achilles Therapeutics: Works on personalized cancer therapies by targeting tumor-specific neoantigens. Their approach is distinct as it focuses on the unique mutations present in individual tumors.

5. Evaxion Biotech: Develops AI-powered immunotherapies, which is a different approach compared to Serinus's focus on drug resistance mechanisms.

6. Immunai: Specializes in multiomics technology to understand the immune system's role in cancer, providing a different angle on cancer treatment compared to Serinus's focus on druggable vulnerabilities.

7. Lantern Pharma: Uses AI for oncology drug discovery, similar to Serinus, but with a broader focus on various cancer types rather than specifically on drug resistance.

8. Freenome: Focuses on blood tests for cancer detection using AI, which is more diagnostic rather than therapeutic, but still relevant in the cancer treatment landscape.

These companies represent a diverse range of approaches to cancer treatment, from drug discovery to immunotherapy, each with unique advantages that differentiate them from Serinus Biosciences.

• Y Combinator
• Illumina Ventures
• Sapir Venture Partners
• Endless Frontier Labs
• Merck Digital
• Phoenix Investment Club

Serinus Biosciences primarily focuses on the biotechnology industry, specifically in the development of drugs to combat cancer drug resistance using artificial intelligence to identify vulnerabilities in resistant tumors.